Detects mutations in myeloproliferative disorders, used alongside other genetic tests.
The MPL mutations W515L and W515K are seen in a number of myeloproliferative disorders such as polycythaemia vera, essential thrombocytosis and idiopathic myelofibrosis. Consider testing in conjunction with or following other molecular tests for these disorders.
MPL (W515 mutations)
To aid in the differential diagnosis and prognostic risk classification for myeloproliferative neoplasms, e.g., polycythaemia vera, essential thrombocythaemia, and primary myelofibrosis.
MPL (Thrombopoietin)
PCR Genotyping
4 weeks
73397– criteria apply
If not MBS eligible please contact 1800 822 999 for details
Standard pathology request form
Blood 6mL EDTA tube or Bone Marrow 4mL EDTA tube
Blood or bone marrow
None
